The Parkinson's therapeutics industry grows at 8.1% CAGR to US$12.83 billion by 2033, propelled by disease-modifying innovations and awareness. Learn about Europe's steady share, male prevalence (1.5x higher), and global shifts toward advanced delivery for 25M+ cases by 2050. https://finance.yahoo.com/news/parkinsons-disease-therapeutics-market-size-143000110.html